This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related letters  • Related articles  • Similar articles in JAMA  Topic Collections  • Lipids and Lipid Disorders  • Alert me on articles by topic

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

JAMA. 2001;285:2486-2497.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

The Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III) constitutes the National Cholesterol Education Program's (NCEP's) updated clinical guidelines for cholesterol testing and management. The full ATP III document is an evidence-based and extensively referenced report that provides the scientific rationale for the recommendations contained in the executive summary. ATP III builds on previous ATP reports and expands the indications for intensive cholesterol-lowering therapy in clinical practice. It should be noted that these guidelines are intended to inform, not replace, the physician's clinical judgment, which must ultimately determine the appropriate treatment for each individual.

BACKGROUND

The third ATP report updates the existing recommendations for clinical management of high blood cholesterol. The NCEP periodically produces ATP clinical updates as warranted by advances in . . . [Full Text of this Article]

LDL CHOLESTEROL: THE PRIMARY TARGET OF THERAPY

RISK ASSESSMENT: FIRST STEP IN RISK MANAGEMENT

Method of Risk Assessment: Counting Major Risk Factors and Estimating 10-Year CHD Risk

Role of Other Risk Factors in Risk Assessment

Metabolic Syndrome

The Link Between Risk Assessment and Cost-effectiveness

PRIMARY PREVENTION WITH LDL-LOWERING THERAPY

SECONDARY PREVENTION WITH LDL-LOWERING THERAPY

LDL-LOWERING THERAPY IN 3 RISK CATEGORIES

CHD and CHD Risk Equivalents

Multiple (2+) Risk Factors and 10-Year Risk of 20%

Multiple (2+) Risk Factors and a 10-Year Risk of 10%-20%

Multiple (2+) Risk Factors and a 10-Year Risk of <10%

0-1 Risk Factor

THERAPEUTIC LIFESTYLE CHANGES IN LDL-LOWERING THERAPY

DRUG THERAPY TO ACHIEVE LDL CHOLESTEROL GOALS

Secondary Prevention: Drug Therapy for CHD and CHD Risk Equivalents

LDL-Lowering Drug Therapy for Primary Prevention

BENEFIT BEYOND LDL LOWERING: THE METABOLIC SYNDROME AS A SECONDARY TARGET OF THERAPY

Management of Underlying Causes of the Metabolic Syndrome

Weight Control

Physical Activity

Specific Treatment of Lipid and Nonlipid Risk Factors

SPECIAL ISSUES

Management of Specific Dyslipidemias

Very High LDL Cholesterol (190 mg/dL)

Elevated Serum Triglycerides

Low HDL Cholesterol

Diabetic Dyslipidemia

Special Considerations for Different Population Groups

Middle-Aged Men (35-65 Years)

Women Aged 45-75 Years

Older Adults (Men 65 Years and Women 75 Years)

Younger Adults (Men 20-35 Years; Women 20-45 Years)

Racial and Ethnic Groups

ADHERENCE TO LDL-LOWERING THERAPY

RELATED LETTERS

Guidelines for Diagnosis and Treatment of High Cholesterol
W. E. Feeman, Jr, Laura Ryan Caldwell, Douglas Iliff, Paul J. Rosch, Bruce L. Ring, Scott M. Grundy, and James I. Cleeman
JAMA. 2001;286(19):2400-2402.
EXTRACT | FULL TEXT  

Contribution of Periodontal Therapy on Individual Cardiovascular Risk Assessment
Francesco D’Aiuto and Maurizio S. Tonetti
Arch Intern Med. 2005;165(16):1920-1921.
EXTRACT | FULL TEXT  

Algorithms for Assessing Cardiovascular Risk in Women
Michael J. Pencina, Ramachandran S. Vasan, and Ralph B. D’Agostino, Sr
JAMA. 2007;298(2):175-176.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Updated Guidelines for Cholesterol Management
Michael S. Lauer and Phil B. Fontanarosa
JAMA. 2001;285(19):2508-2509.
EXTRACT | FULL TEXT  

May 16, 2001
JAMA. 2001;285(19):2521-2522.
EXTRACT | FULL TEXT  

Cholesterol and Atherosclerosis
JAMA. 2001;285(19):2536.
PDF  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Significant associations of metabolic syndrome and its components with silent lacunar infarction in middle aged subjects
Park et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:719-721.
ABSTRACT | FULL TEXT  

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
Hausenloy and Yellon
Heart 2008;94:706-714.
ABSTRACT | FULL TEXT  

Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol
Love-Gregory et al.
Hum Mol Genet 2008;17:1695-1704.
ABSTRACT | FULL TEXT  

Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography: A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden
Ballantyne et al.
Circulation 2008;117:2458-2466.
ABSTRACT | FULL TEXT  

Impact of parity on anthropometric measures of obesity controlling by multiple confounders: a cross-sectional study in Chilean women
Koch et al.
J. Epidemiol. Community Health 2008;62:461-470.
ABSTRACT | FULL TEXT  

Prospective study of alcohol consumption and metabolic syndrome
Baik and Shin
Am. J. Clin. Nutr. 2008;87:1455-1463.
ABSTRACT | FULL TEXT  

Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individuals with the metabolic syndrome
Kallio et al.
Am. J. Clin. Nutr. 2008;87:1497-1503.
ABSTRACT | FULL TEXT  

Are Statins an Option in the Management of Abdominal Aortic Aneurysms?
Paraskevas et al.
VASC ENDOVASCULAR SURG 2008;42:128-134.
ABSTRACT  

Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up
Guasti et al.
Eur Heart J 2008;29:1118-1126.
ABSTRACT | FULL TEXT  

Factors Related to Declining Luteal Function in Women during the Menopausal Transition
Santoro et al.
J. Clin. Endocrinol. Metab. 2008;93:1711-1721.
ABSTRACT | FULL TEXT  

Intra-abdominal Adiposity and Individual Components of the Metabolic Syndrome in Adolescence: Sex Differences and Underlying Mechanisms
Syme et al.
Arch Pediatr Adolesc Med 2008;162:453-461.
ABSTRACT | FULL TEXT  

Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis
Kidambi and Patel
J. Clin. Pathol. 2008;61:588-594.
ABSTRACT | FULL TEXT  

Reference intervals of common serum analytes of Hong Kong Chinese
Chan et al.
J. Clin. Pathol. 2008;61:632-636.
ABSTRACT | FULL TEXT  

Audit of metabolic syndrome in adults prescribed clozapine in community and long-stay in-patient populations
Morgan et al.
Psychiatr. Bull. 2008;32:174-177.
ABSTRACT | FULL TEXT  

Almonds Reduce Biomarkers of Lipid Peroxidation in Older Hyperlipidemic Subjects
Jenkins et al.
J. Nutr. 2008;138:908-913.
ABSTRACT | FULL TEXT  

Usefulness of Childhood Non-High Density Lipoprotein Cholesterol Levels Versus Other Lipoprotein Measures in Predicting Adult Subclinical Atherosclerosis: The Bogalusa Heart Study
Frontini et al.
Pediatrics 2008;121:924-929.
ABSTRACT | FULL TEXT  

Laboratory Assessment of HDL Heterogeneity and Function
Movva and Rader
Clin. Chem. 2008;54:788-800.
ABSTRACT | FULL TEXT  

Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
Zhang et al.
Diabetes 2008;57:1246-1253.
ABSTRACT | FULL TEXT  

Metabolic Syndrome Is Associated With Silent Ischemic Brain Lesions
Bokura et al.
Stroke 2008;39:1607-1609.
ABSTRACT | FULL TEXT  

Macrovascular disease and atherosclerosis in SSc
Hettema et al.
Rheumatology (Oxford) 2008;47:578-583.
ABSTRACT | FULL TEXT  

Prognosis of Transient Neurological Attacks--Reply
Bos et al.
JAMA 2008;299:1772-1773.
FULL TEXT  

Prognosis of Transient Neurological Attacks
Elkind
JAMA 2008;299:1771-1771.
FULL TEXT  

Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus Conference Report From the American Diabetes Association and the American College of Cardiology Foundation
Brunzell et al.
J Am Coll Cardiol 2008;51:1512-1524.
FULL TEXT  

Incidental Findings on Cardiac Multidetector Row Computed Tomography Among Healthy Older Adults: Prevalence and Clinical Correlates
Burt et al.
Arch Intern Med 2008;168:756-761.
ABSTRACT | FULL TEXT  

Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial
Howard et al.
JAMA 2008;299:1678-1689.
ABSTRACT | FULL TEXT  

The Great Debate of 2008--How Low to Go in Preventive Cardiology?
Peterson and Wang
JAMA 2008;299:1718-1720.
FULL TEXT  

Themed Review: Lifestyle Treatment of the Metabolic Syndrome
Janiszewski et al.
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2008;2:99-108.
ABSTRACT  

Egg consumption in relation to cardiovascular disease and mortality: the Physicians' Health Study
Djousse and Gaziano
Am. J. Clin. Nutr. 2008;87:964-969.
ABSTRACT | FULL TEXT  

Clinician's Corner: The Metabolic Syndrome: A Lifestyle Medicine Foe Worthy of a Seek and Destroy Mission
Greenstone
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2008;2:109-112.
ABSTRACT  

Long-term treatment of obese children and adolescents using a telemedicine support programme
Schiel et al.
J Telemed Telecare 2008;14:13-16.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome Is Associated With Circulating Adipokines in Older Adults Across a Wide Range of Adiposity
You et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2008;63:414-419.
ABSTRACT | FULL TEXT  

Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
Brunzell et al.
Diabetes Care 2008;31:811-822.
FULL TEXT  

Physical Activity: Physical Activity and the Metabolic Syndrome: A Review of the Evidence
Churilla and Zoeller
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2008;2:118-125.
ABSTRACT  

Growth Hormone Treatment of Adults with Prader-Willi Syndrome and Growth Hormone Deficiency Improves Lean Body Mass, Fractional Body Fat, and Serum Triiodothyronine without Glucose Impairment: Results from the United States Multicenter Trial
Mogul et al.
J. Clin. Endocrinol. Metab. 2008;93:1238-1245.
ABSTRACT | FULL TEXT  

Association between the Metabolic Syndrome and Serum Cortisol in Overweight Latino Youth
Weigensberg et al.
J. Clin. Endocrinol. Metab. 2008;93:1372-1378.
ABSTRACT | FULL TEXT  

Daily Consumption of a Dark Chocolate Containing Flavanols and Added Sterol Esters Affects Cardiovascular Risk Factors in a Normotensive Population with Elevated Cholesterol
Allen et al.
J. Nutr. 2008;138:725-731.
ABSTRACT | FULL TEXT  

Translating the Diabetes Prevention Program Into an Urban Medically Underserved Community: A nonrandomized prospective intervention study
Seidel et al.
Diabetes Care 2008;31:684-689.
ABSTRACT | FULL TEXT  

Coronary artery disease epidemic in Pakistan: more electrocardiographic evidence of ischaemia in women than in men
Jafar et al.
Heart 2008;94:408-413.
ABSTRACT | FULL TEXT  

Insulin Resistance as a Risk Factor for Carotid Atherosclerosis: A Comparison of the Homeostasis Model Assessment and the Short Insulin Tolerance Test
Sourij et al.
Stroke 2008;39:1349-1351.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome Predicts Incident Stroke: A 14-Year Follow-Up Study in Elderly People in Finland
Wang et al.
Stroke 2008;39:1078-1083.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome: More Than the Sum of Its Components?
Kurth and Logroscino
Stroke 2008;39:1068-1069.
FULL TEXT  

Glucose Homeostasis in Hypertensive Subjects
Korhonen et al.
Hypertension 2008;51:945-949.
ABSTRACT | FULL TEXT  

Gender Difference in Blood Pressure Control and Cardiovascular Risk Factors in Americans With Diagnosed Hypertension
Ong et al.
Hypertension 2008;51:1142-1148.
ABSTRACT | FULL TEXT  

Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
Detrano et al.
NEJM 2008;358:1336-1345.
ABSTRACT | FULL TEXT  

Variation in the 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase Gene Is Associated With Racial Differences in Low-Density Lipoprotein Cholesterol Response to Simvastatin Treatment
Krauss et al.
Circulation 2008;117:1537-1544.
ABSTRACT | FULL TEXT  

Should we dump the metabolic syndrome? No
Alberti and Zimmet
BMJ 2008;336:641-641.
FULL TEXT  

Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events
Kathiresan et al.
NEJM 2008;358:1240-1249.
ABSTRACT | FULL TEXT  

Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
Song and Hardisty
QJM 2008;0:hcn034v1-hcn034.
ABSTRACT | FULL TEXT  

Optimal treatment of carotid artery disease.
Levy et al.
J Am Coll Cardiol 2008;51:979-985.
ABSTRACT | FULL TEXT  

Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women.
Rossi et al.
J Am Coll Cardiol 2008;51:997-1002.
ABSTRACT | FULL TEXT  

Atrial Fibrillation Susceptibility in Metabolic Syndrome: Simply the Sum of Its Parts?
Nguyen and Benditt
Circulation 2008;117:1249-1251.
FULL TEXT  

Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study
Watanabe et al.
Circulation 2008;117:1255-1260.
ABSTRACT | FULL TEXT  

Vascular consequences of metabolic syndrome in early life
Visseren
Eur Heart J 2008;29:693-694.
FULL TEXT  

Menopausal symptoms and adjuvant therapy-associated adverse events
Hadji
Endocr Relat Cancer 2008;15:73-90.
ABSTRACT | FULL TEXT  

Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease
Motard-Belanger et al.
Am. J. Clin. Nutr. 2008;87:593-599.
ABSTRACT | FULL TEXT  

Serum concentrations and expressions of serum amyloid A and leptin in adipose tissue are interrelated: the Genobin Study
Lappalainen et al.
Eur J Endocrinol 2008;158:333-341.
ABSTRACT | FULL TEXT  

Metabolic syndrome and the menopause
Kaaja
Menopause Int 2008;14:21-25.
ABSTRACT | FULL TEXT  

Primary prevention of coronary heart disease in women
Rees et al.
Menopause Int 2008;14:40-45.
ABSTRACT | FULL TEXT  

Serum Total and High-Density Lipoprotein Phospholipid Levels in a Population-Based Study and Relationship to Risk of Metabolic Syndrome and Coronary Disease
Hergenc et al.
ANGIOLOGY 2008;59:26-35.
ABSTRACT  

Achieving Vascular Risk Factor Targets: A Survey of a London General Practice
Levine et al.
ANGIOLOGY 2008;59:36-46.
ABSTRACT  

Aortic Size Assessment by Noncontrast Cardiac Computed Tomography: Normal Limits by Age, Gender, and Body Surface Area
Wolak et al.
J Am Coll Cardiol Img 2008;1:200-209.
ABSTRACT | FULL TEXT  

HDL-cholesterol modulation and its impact on the management of cardiovascular risk
Ferns and Keti
Ann Clin Biochem 2008;45:122-128.
ABSTRACT | FULL TEXT  

Work stress and coronary heart disease: what are the mechanisms?
Chandola et al.
Eur Heart J 2008;29:640-648.
ABSTRACT | FULL TEXT  

The Increasing Prevalence of Metabolic Syndrome among Finnish Men and Women over a Decade
Hu et al.
J. Clin. Endocrinol. Metab. 2008;93:832-836.
ABSTRACT | FULL TEXT  

Can Fishing for New Genes Catch Patients at Risk of Coronary Artery Disease?
Emmerich and Ridker
Clin. Chem. 2008;54:453-455.
FULL TEXT  

Lipid Extract of Nostoc commune var. sphaeroides Kutzing, a Blue-Green Alga, Inhibits the Activation of Sterol Regulatory Element Binding Proteins in HepG2 Cells
Rasmussen et al.
J. Nutr. 2008;138:476-481.
ABSTRACT | FULL TEXT  

Plasminogen Activator Inhibitor-1 Polymorphism (4G/5G) Predicts Recurrence in Nonhyperlipidemic Postinfarction Patients
Corsetti et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:548-554.
ABSTRACT | FULL TEXT  

Association Between Cardiovascular Risk Profiles and the Presence and Extent of Different Types of Coronary Atherosclerotic Plaque as Detected by Multidetector Computed Tomography
Bamberg et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:568-574.
ABSTRACT | FULL TEXT  

Chronic Kidney Disease in Latin America: Time to Improve Screening and Detection
Cusumano and Gonzalez Bedat
CJASN 2008;3:594-600.
ABSTRACT | FULL TEXT  

Metabolic syndrome: the dysmetabolic state of dysfunctional adipose tissue and insulin resistance
Despres and Brewer
Eur Heart J Suppl 2008;10:B1-B3.
FULL TEXT  

Risk of type 2 diabetes mellitus and coronary heart disease: a pivotal role for metabolic factors
Wilson and Meigs
Eur Heart J Suppl 2008;10:B11-B15.
ABSTRACT | FULL TEXT  

From individual risk factors and the metabolic syndrome to global cardiometabolic risk
Despres et al.
Eur Heart J Suppl 2008;10:B24-B33.
ABSTRACT | FULL TEXT  

Statin Therapy for Stroke Prevention
Nassief and Marsh
Stroke 2008;39:1042-1048.
ABSTRACT | FULL TEXT  

The Role of the Diabetes Educator: Patient Case Scenarios
Haas
The Diabetes Educator 2008;34:32S-36S.
ABSTRACT | FULL TEXT  

Cardiovascular Disease in Transplant Recipients: Current and Future Treatment Strategies
Gill
CJASN 2008;3:S29-S37.
ABSTRACT | FULL TEXT  

New-Onset Diabetes Mellitus in the Kidney Recipient: Diagnosis and Management Strategies
Bloom and Crutchlow
CJASN 2008;3:S38-S48.
ABSTRACT | FULL TEXT  

Dyslipidaemia as a predictor of hypertension in middle-aged men
Laaksonen et al.
Eur Heart J 2008;0:ehn061v1-8.
ABSTRACT | FULL TEXT  

Obstructive Sleep Apnea and Metabolic Syndrome: Alterations in Glucose Metabolism and Inflammation
Tasali and Ip
Proc Am Thorac Soc 2008;5:207-217.
ABSTRACT | FULL TEXT  

General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D'Agostino et al.
Circulation 2008;117:743-753.
ABSTRACT | FULL TEXT  

Strategies for prescribing statins
Donner-Banzhoff and Sonnichsen
BMJ 2008;336:288-289.
FULL TEXT  

Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study
Rosito et al.
Circulation 2008;117:605-613.
ABSTRACT | FULL TEXT  

Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease
Poulain et al.
Chronic Respiratory Disease 2008;5:35-41.
ABSTRACT  

Review: Aspirin and Diabetes Mellitus: revisiting an old player
Manrique et al.
Therapeutic Advances in Cardiovascular Disease 2008;2:37-42.
ABSTRACT  

Carotid atherosclerotic alterations in systemic lupus erythematosus patients treated at a Brazilian university setting
Telles et al.
Lupus 2008;17:105-113.
ABSTRACT  

The LDL to HDL Cholesterol Ratio as a Valuable Tool to Evaluate Coronary Heart Disease Risk
Fernandez and Webb
J. Am. Coll. Nutr. 2008;27:1-5.
ABSTRACT | FULL TEXT  

Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State
Devaraj et al.
J. Clin. Endocrinol. Metab. 2008;93:578-583.
ABSTRACT | FULL TEXT  

Hydroxypropylmethylcellulose and Methylcellulose Consumption Reduce Postprandial Insulinemia in Overweight and Obese Men and Women
Maki et al.
J. Nutr. 2008;138:292-296.
ABSTRACT | FULL TEXT  

Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults
Fleischman et al.
Diabetes Care 2008;31:289-294.
ABSTRACT | FULL TEXT  

25-Hydroxyvitamin D, IGF-1, and Metabolic Syndrome at 45 Years of Age: A Cross-Sectional Study in the 1958 British Birth Cohort
Hypponen et al.
Diabetes 2008;57:298-305.
ABSTRACT | FULL TEXT  

Activation of Peroxisome Proliferator-Activated Receptor (PPAR){delta} Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men
Riserus et al.
Diabetes 2008;57:332-339.
ABSTRACT | FULL TEXT  

Mas Deficiency in FVB/N Mice Produces Marked Changes in Lipid and Glycemic Metabolism
Santos et al.
Diabetes 2008;57:340-347.
ABSTRACT | FULL TEXT  

Plasma Uric Acid and the Risk of Type 2 Diabetes in a Chinese Community
Chien et al.
Clin. Chem. 2008;54:310-316.
ABSTRACT | FULL TEXT